Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects

NCT03234751 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Continous IV infusion of Nesiritide
DRUG: Hyperinsulinemic euglycemic clamp
DRUG: Placebo

Sponsor

AdventHealth Translational Research Institute